Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / DMAC - DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds

DMAC - DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds

DiaMedica Therapeutics Inc.

2025-05-14 11:06:10 ET

More on DiaMedica Therapeutics

For further details see:

DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds

Stock Information
Company Name: DiaMedica Therapeutics Inc.
Stock Symbol: DMAC
Market: NASDAQ
Website: diamedica.com
Menu
DMAC DMAC Quote DMAC Short DMAC News DMAC Articles DMAC Message Board
Get DMAC Alerts

News, Short Squeeze, Breakout and More Instantly...